• De Roeck A
    Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.
    Acta Neuropathol. 2017 Apr 27. doi: 10.1007/s00401-017-1714-x. [Epub ahead of print]
  • Lloret-Villas A, Varusai TM, Juty N, Laibe C, Le NovÈre N, Hermjakob H, Chelliah V.
    The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions.
    CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):73-86. doi: 10.1002/psp4.12155. Epub 2017 Jan 7.
  • Musante V. et al.
    Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition
    eLife 6; doi: 10.7554/eLife.24998
  • Viollet C, Simon A, Tolle V, Labarthe A, Grouselle D, Loe-Mie Y, Simonneau M, Martel G, Epelbaum J
    Somatostatin-IRES-Cre Mice: Between Knockout and Wild-Type?
    Front Endocrinol (Lausanne). 2017 Jun 19;8:131. doi: 10.3389/fendo.2017.00131. eCollection 2017.
  • Haziza S et al.
    Fluorescent nanodiamond tracking reveals intraneuronal transport abnormalities induced by brain-disease-related genetic risk factors.
    Nat Nanotechnol. 2017 May;12(4):322-328. doi: 10.1038/nnano.2016.260. Epub 2016 Nov 28.



  • Hossinig AM et al.
    Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer´s disease donor as a model for investigating AD-associated gene regulatory networks
    BMC Genomics  2014, 16:8
  • Karolien B et al.
    Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
    Molecular Neurodegeneration 2015 10:30 doi:10.1186/s13024-015-0024-9
  • Van Cauwenberghe C, Van Broeckhoven C, Sleegers K.
    The genetic landscape of Alzheimer disease: clinical implications and perspectives.
    Genet Med. 2016 May;18(5):421-30. doi: 10.1038/gim.2015.117. Epub 2015 Aug 27.
  • Cuyvers E et al.
    Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Lancet Neurol. 2015 Aug;14(8):814-822. doi: 10.1016/S1474-4422(15)00133-7. Epub 2015 Jun 30.
  • Sleegers K, et al.
    A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42.
    Alzheimers Dement. 2015 Dec;11(12):1452-1460. doi: 10.1016/j.jalz.2015.02.013. Epub 2015 Jun 15.
  • Cuyvers E et al.
    Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study.
    Neurobiol Aging. 2015 May;36(5):2005.e15-22. doi: 10.1016/j.neurobiolaging.2015.02.014. Epub 2015 Feb 19.



Last update on 2017-07-22

AgedBrainSYSBIO has received funding from the European Union’s Seventh Framework Programme for research,
technological development and demonstration under grant agreement No 305299
european flag blueyellow standard